| Issue Date |
Title |
Author(s) |
| 2008 |
Adenovirus-mediated PDCD5 gene transfer sensitizes K562 cells to apoptosis induced by idarubicin in vitro and in vivo |
Ruan, Guo-Rui;Zhao, Hong-Shan;Chang, Yan;Li, Jin-Lan;Qin, Ya-Zhen;Liu, Yan-Rong;Chen, Shan-Shan;Huang, Xiao-Jun |
| 2007 |
Analysis of leukemia associated immunophenotype (LAIP) in 610 patients with acute myeloid leukemia and their significant in minimal residual disease detection |
Liu, Yan-rong;Wang, Ya-zhe;Chang, Yan;Chen, Shan-Shan;Fu, Jia-yu;Wang, Hui |
| 2014 |
The clinical value of the quantitative detection of four cancer-testis antigen genes in multiple myeloma |
Zhang, Yao;Bao, Li;Lu, Jin;Liu, Kai-Yan;Li, Jin-Lan;Qin, Ya-Zhen;Chen, Huan;Li, Ling-Di;Kong, Yuan;Shi, Hong-Xia;Lai, Yue-Yun;Liu, Yan-Rong;Jiang, Bin;Chen, Shan-Shan;Huang, Xiao-Jun;Ruan, Guo-Rui |
| 2011 |
Imatinib Mesylate Is Superior to Allogeneic Hematopoietic Stem Cell Transplantation As the First-Line Therapy for Patients with Chronic Myeloid Leukemia in the Early Chronic Phase |
Jiang, Qian;Xu, Lan-Ping;Liu, Dai-Hong;Liu, Kai-Yan;Jiang, Bin;Zhang, Xiao-hui;Wang, Yu;Chen, Shan-Shan;Mo, Xiao-Dong;Zhao, Xiang-Yu;Chen, Huan;Chen, Yu-Hong;Han, Wei;Jiang, Hao;Qin, Ya-Zhen;Liu, Yan-Rong;Lai, Yue-yun;Shi, Hong-Xia;Lv, Meng;Huang, Xiao Jun |
| 2011 |
Imatinib mesylate versus allogeneic hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia in the accelerated phase |
Jiang, Qian;Xu, Lan-Ping;Liu, Dai-Hong;Liu, Kai-Yan;Chen, Shan-Shan;Jiang, Bin;Jiang, Hao;Chen, Huan;Chen, Yu-Hong;Han, Wei;Zhang, Xiao-Hui;Wang, Yu;Qin, Ya-Zhen;Liu, Yan-Rong;Lai, Yue-Yun;Huang, Xiao-Jun |
| 2010 |
Imatinib Mesylate Versus Allogeneic HSCT for Patients with Chronic Myelogenous Leukemia In Accelerated Phase: A Single Center Experience In China After a 9-Year Follow-up. |
Jiang, Qian;Xu, Lan-Ping;Liu, Dai-Hong;Liu, Kaiyan;Chen, Shan-Shan;Jiang, Bin;Jiang, Hao;Chen, Huan;Chen, Yu-Hong;Han, Wei;Zhang, Xiao-hui;Wang, Yu;Qin, Ya-Zhen;Liu, Yan-Rong;Lai, Yue-yun;Huang, Xiao Jun |
| 2010 |
MPL W515L/K mutations in 343 Chinese adults with JAK2V617F mutation-negative chronic myeloproliferative disorders detected by a newly developed RQ-PCR based on Taq Man MGB probes |
Ruan, Guo-Rui;Jiang, Bin;Li, Ling-Di;Niu, Ji-Hong;Li, Jin-Lan;Xie, Min;Qin, Ya-Zhen;Liu, Yan-Rong;Huang, Xiao-Jun;Chen, Shan-Shan |
| 2009 |
Nucleophosmin mutations in Chinese adults with acute myelogenous leukemia |
Ruan, Guo-Rui;Li, Jin-Lan;Qin, Ya-Zhen;Li, Ling-Di;Xie, Min;Chang, Yan;Zhang, Yan;Liu, Yan-Rong;Jiang, Bin;Chen, Shan-Shan;Huang, Xiao-Jun |
| 2016 |
Prognostic impact of IKZF1 deletion in adults with common B-cell acute lymphoblastic leukemia |
Yao, Qiu-Mei;Liu, Kai-Yan;Gale, Robert Peter;Jiang, Bin;Liu, Yan-Rong;Jiang, Qian;Jiang, Hao;Zhang, Xiao-Hui;Zhang, Mei-Jie;Chen, Shan-Shan;Huang, Xiao-Jun;Xu, Lan-Ping;Ruan, Guo-Rui |
| 2015 |
A rapid, highly accurate method for quantifying CALR mutant allele burden in persons with myeloproliferative neoplasms |
Yao, Qiu-Mei;Zhou, Jiao;Gale, Robert Peter;Li, Jin-Lan;Li, Ling-Di;Li, Ning;Chen, Shan-Shan;Ruan, Guo-Rui |
| 2011 |
Seven-year response to imatinib as initial treatment versus re-treatment in Chinese patients with chronic myelogenous leukemia in the chronic phase |
Jiang, Hao;Chen, Shan-Shan;Jiang, Bin;Jiang, Qian;Qin, Ya-Zhen;Lai, Yue-Yun;Huang, Xiao-Jun |
